Clorox (CLX) Downgraded by Deutsche Bank

Deutsche Bank downgraded shares of Clorox (NYSE:CLX) from a hold rating to a sell rating in a research report sent to investors on Wednesday morning, Marketbeat Ratings reports. The firm currently has $123.00 target price on the stock.

A number of other equities analysts have also recently issued reports on the company. Barclays set a $131.00 target price on Clorox and gave the stock a hold rating in a report on Saturday, October 6th. Zacks Investment Research cut Clorox from a buy rating to a hold rating in a report on Friday, October 5th. Argus upgraded Clorox from a hold rating to a buy rating and set a $175.00 target price for the company in a report on Tuesday, September 25th. ValuEngine upgraded Clorox from a hold rating to a buy rating in a report on Saturday, September 22nd. Finally, Atlantic Securities assumed coverage on Clorox in a report on Thursday, September 20th. They set a neutral rating and a $151.00 target price for the company. Four research analysts have rated the stock with a sell rating, eight have given a hold rating and four have issued a buy rating to the stock. Clorox has a consensus rating of Hold and an average target price of $137.21.

CLX stock opened at $144.84 on Wednesday. The stock has a market cap of $19.21 billion, a price-to-earnings ratio of 23.14, a PEG ratio of 3.11 and a beta of 0.36. The company has a debt-to-equity ratio of 3.15, a current ratio of 1.09 and a quick ratio of 0.67. Clorox has a 1 year low of $113.57 and a 1 year high of $153.38.

Clorox (NYSE:CLX) last released its earnings results on Thursday, August 2nd. The company reported $1.66 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.58 by $0.08. The firm had revenue of $1.69 billion during the quarter, compared to analysts’ expectations of $1.72 billion. Clorox had a return on equity of 103.18% and a net margin of 13.44%. The company’s revenue was up 2.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.53 EPS. As a group, sell-side analysts forecast that Clorox will post 6.41 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 16th. Stockholders of record on Wednesday, October 31st will be issued a $0.96 dividend. This represents a $3.84 annualized dividend and a dividend yield of 2.65%. The ex-dividend date of this dividend is Tuesday, October 30th. Clorox’s payout ratio is 61.34%.

In other news, EVP Linda J. Rendle sold 382 shares of the firm’s stock in a transaction dated Thursday, September 6th. The stock was sold at an average price of $148.32, for a total value of $56,658.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Dawn C. Willoughby sold 3,387 shares of the firm’s stock in a transaction dated Wednesday, September 5th. The shares were sold at an average price of $148.01, for a total value of $501,309.87. The disclosure for this sale can be found here. Insiders sold a total of 29,268 shares of company stock valued at $4,196,686 in the last 90 days. 1.00% of the stock is owned by corporate insiders.

Several hedge funds and other institutional investors have recently made changes to their positions in CLX. Cornerstone Wealth Management LLC bought a new position in Clorox during the second quarter worth about $105,000. Ostrum Asset Management bought a new position in Clorox during the first quarter worth about $112,000. Fort L.P. bought a new position in Clorox during the second quarter worth about $129,000. Livingston Group Asset Management CO operating as Southport Capital Management bought a new position in Clorox during the third quarter worth about $130,000. Finally, Whittier Trust Co. of Nevada Inc. grew its holdings in Clorox by 1,297.4% during the second quarter. Whittier Trust Co. of Nevada Inc. now owns 1,621 shares of the company’s stock worth $148,000 after purchasing an additional 1,505 shares during the period. Institutional investors own 78.36% of the company’s stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

See Also: Conference Calls

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply